For the Inventor, By the Inventor

Enter assignee name

MA, United States of America

Worcester Foundation for Experimental Biology

Calculating rank

USPTO Granted Patents = 18

Forward Citations = 2,104

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Sudhir Agrawal (10 out of 153 patents)

Paul C Zamecnik (10 out of 21 patents)

Thoru Pederson (4 out of 8 patents)

4. Sandra Mayrand (4 out of 4 patents)

5. Barbara J Walker (3 out of 3 patents)

6. Alonzo H Ross (2 out of 4 patents)

7. John Goodchild (2 out of 6 patents)

8. Dorota K Poluha (2 out of 2 patents)

9. Wojciech Poluha (2 out of 2 patents)

10. Hagen Bayley (2 out of 2 patents)

11. Valeri Metelev (1 out of 6 patents)

12. Mahesh B Lachyankar (1 out of 2 patents)

13. Richard A Cardullo (1 out of 3 patents)

14. David E Wolf (1 out of 6 patents)

15. Josef M Leiter (1 out of 2 patents)

18 patents: Sort by Forward Citations

1. 5824776 - Cell-targeted lytic pore-forming agents (1998-10-20),

2. 5817771 - Cell-targeted lytic pore-forming agents (1998-10-06),

3. 5789187 - Identification of differentiation factor receptors which inhibit the (1998-08-04),

4. 5777078 - Triggered pore-forming agents (1998-07-07),

5. 5652355 - Hybrid oligonucleotide phosphorothioates (1997-07-29),

6. 5635377 - Method of site-specific alteration of RNA and production of encoded (1997-06-03),

7. 5612469 - Enhancement of ribozyme catalytic activity by a neighboring facilitator (1997-03-18),

8. 5559221 - Method of separating oligonucleotides from a mixture (1996-09-24),

9. 5387520 - Treatment of tumor cells in vitro with neurotrophic factors and cell (1995-02-07),

10. 5366878 - Method of site-specific alteration of RNA and production of encoded (1994-11-22),

11. 5352578 - Method of separating oligonucleotides from a mixture (1994-10-04),

12. 5220007 - Method of site-specific alteration of RNA and production of encoded (1993-06-15),

13. 5194428 - Inhibition of influenza virus replication by oligonucleotide (1993-03-16),

14. 5149798 - Process for synthesizing oligonucleotides and their analogs adaptable to (1992-09-22),

15. 5149797 - Method of site-specific alteration of RNA and production of encoded (1992-09-22),

Company Overview

The Worcester Foundation for Experimental Biology is a prominent research institution located in Massachusetts, specializing in biological sciences. The foundation focuses on advancing knowledge in areas such as molecular biology, genetics, and biochemistry, contributing significantly to the understanding of biological processes and their applications in medicine. Through innovative research and collaboration, it aims to foster breakthroughs that enhance human health and well-being, positioning itself as a leader in experimental biology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

18 Patents

#2 in undefined, MA

#1,103 in Massachusetts

#17,988 in US

#34,283 in the World

MA, United States of America

Worcester Foundation for Experimental Biology

Forward Citations = 2,104

21 inventors:

Sudhir Agrawal (10 out of 153 patents)

Paul C Zamecnik (10 out of 21 patents)

Thoru Pederson (4 out of 8 patents)

4. Sandra Mayrand (4 out of 4 patents)

5. Barbara J Walker (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Worcester Foundation for Experimental Biology. Retrieved from https://idiyas.com/company/worcester-foundation-for-experimental-biology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…